Hepatitis C and liver transplantation (original) (raw)
AI-generated Abstract
Cirrhosis due to hepatitis C virus (HCV) infection is the leading cause for liver transplantation in adults, accounting for roughly half of all transplant cases. The HCV-infected population faces significant challenges regarding the management of recurrent HCV disease post-transplant, including limited efficacy of current antiviral therapies and a high rate of graft disease recurrence. Continued investigation is critical to enhance understanding of disease progression and improve transplant outcomes through novel treatment approaches.
Sign up for access to the world's latest research.
checkGet notified about relevant papers
checkSave papers to use in your research
checkJoin the discussion with peers
checkTrack your impact
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.